THERAPEUTIC AREAS

NASH-HCC

• STAM™ model

Primary biliqry cirrhosis

• Bile duct ligation (BDL) model

ALF

• CCl₄-induced acute liver failure model
• Concanavalin A-induced acute liver failure model
• D-gal/LPS-induced acute liver failure model
• TAA-induced acute liver failure model

Alzheimer’s disease

• icv-STZ model

Systemic sclerosis

• SSc model

Metabolic diseases

• nSTZ model
• MCD model
• ob/ob model

Oncology

• DEN-CCl₄ liver cancer model
• Xenograft tumor models

CKD

• UUO-induced renal fibrosis model
• Adriamycin-induced nephropathy model

IBD

• DSS-induced colitis model

IPF

• Bleomycin-induced pulmonary fibrosis model

COPD

• Porcine Pancreatic Elastase (PPE) model

Cirrhosis

• CCl₄-induced liver fibrosis model